COMPARATIVE EFFECTS OF VALPROATE, ANXIOLYTIC, OR ANXIOGENIC DRUGS ON THE LIGHT DARK AVERSION TEST

被引:15
作者
DEANGELIS, L
机构
[1] Institute of Pharmacology, School of Medicine, University of Trieste, Trieste
关键词
CLONIDINE; DIAZEPAM; VERAPAMIL; PENTYLENETETRAZOL;
D O I
10.1002/ddr.430250408
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The potential anxiolytic-like effects of 200, 300, and 400 mg/kg i.p. of sodium valproate were evaluated in the light/dark aversion test in mice. For comparison, we included the reference anxiolytic drug, diazepam (2.5, 5.0, 10 mg/kg i.p.) as well as putative anxiolytics, i.e., clonidine (0.015, 0.030, 0.060 mg/kg i.p.), verapamil (5, 10, 20 mg/kg i.p.), or anxiogenic drugs, pentylenetetrazol (5, 10, 15 mg/kg i.p.). Results showed that control mice preferred the dark compartment where they spent approximately 70% of their time. After administration of 5 and 1 0 mg/kg i.p. of diazepam or 400 mg/kg i.p. of valproate, the increase in exploratory behavior in the lit area was associated with an increase both in the number of transitions and in the time spent in the lit area. Pretreatment with 0.030 and 0.060 mg/kg i.p. clonidine caused an increase in the time spent in the lit area. Verapamil had no significant effect on both measures of this test. Pentylenetetrazol, in doses which did not cause convulsions, was anxiogenic. In conclusion, these results in the light/dark aversion test are consistent with clinical data showing that valproate, a GABA-agonist, and clonidine, an alpha-2 adrenoceptor agonist, possess anxiolytic properties.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 25 条
[1]   ANXIOGENIC EFFECTS OF METHYL-BETA-CARBOLINE-3-CARBOXYLATE IN A LIGHT DARK CHOICE SITUATION [J].
BELZUNG, C ;
MISSLIN, R ;
VOGEL, E ;
DODD, RH ;
CHAPOUTHIER, G .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 28 (01) :29-33
[2]  
BELZUNG C, 1988, PSYCHOPHARMACOLOGY, V95, P516
[3]   YOHIMBINE INDUCED ANXIETY AND INCREASED NORADRENERGIC FUNCTION IN HUMANS - EFFECTS OF DIAZEPAM AND CLONIDINE [J].
CHARNEY, DS ;
HENINGER, GR ;
REDMOND, DE .
LIFE SCIENCES, 1983, 33 (01) :19-29
[4]   EXPLORATION OF MICE IN A BLACK AND WHITE TEST BOX - VALIDATION AS A MODEL OF ANXIETY [J].
COSTALL, B ;
JONES, BJ ;
KELLY, ME ;
NAYLOR, RJ ;
TOMKINS, DM .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 32 (03) :777-785
[5]   ACTIONS OF BUSPIRONE IN A PUTATIVE MODEL OF ANXIETY IN THE MOUSE [J].
COSTALL, B ;
KELLY, ME ;
NAYLOR, RJ ;
ONAIVI, ES .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (07) :494-500
[6]   PRELIMINARY-REPORT OF A SIMPLE ANIMAL BEHAVIOR MODEL FOR THE ANXIOLYTIC EFFECTS OF BENZODIAZEPINES [J].
CRAWLEY, J ;
GOODWIN, FK .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1980, 13 (02) :167-170
[7]  
CZYRAK A, 1988, PSYCHOPHARMACOLOGY, V96, pS11
[8]   ABSENCE OF ANXIOLYTIC EFFECTS OF CALCIUM-CHANNEL ANTAGONISTS [J].
DEANGELIS, L .
DRUG DEVELOPMENT RESEARCH, 1991, 23 (04) :359-364
[9]  
DEANGELIS L, 1990, PHARMACEUT RES, V22, P151
[10]   SODIUM VALPROATE AND CHLORDIAZEPOXIDE IN THE ELEVATED PLUS-MAZE TEST OF ANXIETY IN THE RAT [J].
FILE, SE ;
ARANKO, K .
NEUROPSYCHOBIOLOGY, 1988, 20 (02) :82-86